AI Healthcare Boom Gains Speed as Regulators and Innovators Align
Express News | GE Healthcare : UBS Raises to Neutral From Sell; Cuts Target Price to $73 From $74
Goldman Sachs Maintains GE HealthCare Technologies(GEHC.US) With Buy Rating, Cuts Target Price to $82
Results: GE HealthCare Technologies Inc. Beat Earnings Expectations And Analysts Now Have New Forecasts
ESTRO 2025 Congress: GE HealthCare to Expand Its Radiation Oncology Portfolio and Introduce New AI-enabled Solutions
J.P. Morgan Remains a Hold on GE Healthcare Technologies Inc (GEHC)
J&J-backed HistoSonics Explores Sale at $2.5 Billion Valuation, FT Reports
Research Alert: CFRA Keeps Hold Opinion On Shares Of Ge Healthcare Technologies Inc.
BofA Securities Maintains GE HealthCare Technologies(GEHC.US) With Hold Rating, Cuts Target Price to $82
Wells Fargo Maintains GE HealthCare Technologies(GEHC.US) With Buy Rating, Cuts Target Price to $89
Jefferies Maintains GE HealthCare Technologies(GEHC.US) With Buy Rating, Cuts Target Price to $95
GE HealthCare's Strong Q1 Took Back Seat To Tariffs, Analyst Sees 2026 Tariff Impact Less Than 2025
GE Hlthcr Techs Is Maintained at Buy by Goldman Sachs
BTIG Research Adjusts GE Healthcare Technologies Price Target to $82 From $95
Stifel Nicolaus Adjusts GE Healthcare Technologies Price Target to $90 From $104
Goldman Sachs Adjusts GE Healthcare Technologies Price Target to $82 From $94
Oppenheimer Adjusts GE Healthcare Technologies Price Target to $89 From $100
GE Hlthcr Techs Is Maintained at Overweight by Wells Fargo
Express News | Evercore ISI Group Maintains Outperform on GE HealthCare Techs, Lowers Price Target to $85
Strong Q1 Performance and Strategic Initiatives Drive Buy Rating for GE Healthcare Technologies Inc